Origin & tradition
Yun Zhi (云芝) is used in Chinese medicine as an immune and liver tonic; its extract PSK is an approved adjuvant in parts of Asia.
Eastern tradition · Functional Mushroom
A medicinal mushroom whose PSK/PSP polysaccharides have the strongest clinical record in immune oncology support.
Data definition. Matched records include all indexed medical endpoints for this intervention — not only longevity. Longevity-relevant records are screened separately and cited in the evidence summary below. Counts are matched-record volumes, not de-duplicated trials and not efficacy claims.
Yun Zhi (云芝) is used in Chinese medicine as an immune and liver tonic; its extract PSK is an approved adjuvant in parts of Asia.
Key active: PSK / PSP polysaccharides (botanical extract).
PSK and PSP are immunomodulating polysaccharides with human oncology-adjuvant trials; longevity relevance is via immune resilience (immunosenescence), not direct lifespan data.
Effect summary
| Health outcome | Effect | Magnitude | Grade |
|---|---|---|---|
| Immune function (NK cells, cancer adjuvant) | Increases | Strong | A |
| Gut microbiome diversity | Increases | Moderate | B |
| NK cell activity | Increases | Moderate | B |
| Fatigue (cancer-related) | Decreases | Minor | C |
Grade: A = robust RCTs · B = several RCTs / meta-analysis · C = limited or mixed RCTs · D = observational or early data
Dosage guidance
PSK (krestin) is approved as cancer adjuvant in Japan. PSP is the variant studied in Chinese research. Whole mushroom powder has less concentrated active compounds — use extracts for therapeutic doses.
Informational only — not a prescription or personalised medical advice. Consult a qualified clinician before starting any supplement or medication.
Evidence summary
Human immune/oncology-adjuvant trials; aging link via immunity
PSK and PSP are immunomodulating polysaccharides with human oncology-adjuvant trials; longevity relevance is via immune resilience (immunosenescence), not direct lifespan data.
According to PubMed and ClinicalTrials.gov: trial counts from ClinicalTrials.gov, peer-reviewed literature from PubMed. Counts auto-refresh weekly; last checked 2026-07-19. They include trials across many endpoints, not only longevity.
Informational only — not medical advice, a treatment claim, or a substitute for a qualified clinician. Evidence strength varies; we show mixed and null results on purpose.
Evidence collections
Compare the evidence
Suppliers